77
Views
6
CrossRef citations to date
0
Altmetric
Original Research

The Chinese herbal formula Fuzheng Quxie Decoction attenuates cognitive impairment and protects cerebrovascular function in SAMP8 mice

, , , , , , , & show all
Pages 3037-3051 | Published online: 09 Nov 2018

References

  • BucknerRLMemory and Executive Function in Aging and ADNeuron200444119520815450170
  • Alzheimer’s disease facts and figuresAlzheimers Dement2017134325373
  • SavelieffMGNamGKangJLeeHJLeeMLimMHDevelopment of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last DecadeChem Rev2018 Epub810
  • MakinSThe amyloid hypothesis on trialNature20185597715S4S730046080
  • Grundke-IqbalIIqbalKTungYCQuinlanMWisniewskiHMBinderLIAbnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathologyProc Natl Acad Sci U S A19868313491349173088567
  • BehlCAmyloid in Alzheimer’s Disease: Guilty Beyond Reasonable Doubt?Trends Pharmacol Sci2017381084985128826585
  • HawkesNMerck ends trial of potential Alzheimer’s drug verubecestatBMJ2017356j84528202490
  • HolmesCBocheDWilkinsonDLong-term effects of Aβ42 immunisation in Alzheimer’s disease: follow-up of a randomised, placebo-controlled phase I trialLancet2008372963421622318640458
  • KarranEHardyJA critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer diseaseAnn Neurol201476218520524853080
  • LovestoneSBoadaMDuboisBA phase II trial of tideglusib in Alzheimer’s diseaseJ Alzheimers Dis2015451758825537011
  • GauthierSFeldmanHHSchneiderLSEfficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer’s disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trialLancet2016388100622873288427863809
  • MarkesberyWRCarneyJMOxidative Alterations in Alzheimer’s DiseaseBrain Pathol201091133146
  • ZattaPDragoDBologninSSensiSLAlzheimer’s disease, metal ions and metal homeostatic therapyTrends Pharmacol Sci200930734635519540003
  • PatelSRaufAAdaptogenic herb ginseng (Panax) as medical food: Status quo and future prospectsBiomed Pharmacother20178512012727930975
  • WangYYangGGongJGinseng for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsCurr Top Med Chem201616552953626268331
  • YangYJiaXFengJFuzheng Quxie Decoction Ameliorates Learning and Memory Impairment in SAMP8 Mice by Decreasing Tau HyperphosphorylationEvid Based Complement Alternat Med2017201720593425429422936
  • HuangMJiangXLiangYLiuQChenSGuoYBerberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer’s diseaseExp Gerontol201791253328223223
  • WangSYLiuJPJiWWQifu-Yin attenuates AGEs-induced Alzheimer-like pathophysiological changes through the RAGE/NF-κB pathwayChin J Nat Med2014121292092825556063
  • LiuMWeiYYangYEffects and Mechanism of Huannao Yicong Decoction Extract on the Ethology of Transgenic APP/PS1 MiceEvid Based Complement Alternat Med201720172950206729422937
  • WangZYLiuJGWeiYHuannao Yicong Formula () regulates γ-secretase activity through APH-1 and PEN-2 gene ragulation pathways in hippocampus of APP/PS1 double transgenic miceChin J Integr Med201723427027828120208
  • YangYLiuJPFangJYEffect and Safety of Huannao Yicong Formula () on Patients with Mild-to-Moderate Alzheimer’s Disease: A Randomized, Double-Blinded, Donepezil-Controlled TrialChin J Integr Med Epub2018814
  • WangQLiHWangFXHuannao Yicong Decoction () extract reduces inflammation and cell apoptosis in Aβ1–42-induced Alzheimer’s disease model of ratsChin J Integr Med201723967268027022730
  • LiSZhangBTraditional Chinese medicine network pharmacology: theory, methodology and applicationChin J Nat Med201311211012023787177
  • YangYA-OXa-OJFengJA-OFuzheng Quxie Decoction Ameliorates Learning and Memory Impairment in SAMP8 Mice by Decreasing Tau HyperphosphorylationEvid Based Complement Alternat Med20172017593425429422936
  • RuJLiPWangJTCMSP: a database of systems pharmacology for drug discovery from herbal medicinesJ Cheminform2014611324735618
  • ChenCYTCM Database@Taiwan: the world’s largest traditional Chinese medicine database for drug screening in silicoPLoS One201161e1593921253603
  • XueRFangZZhangMYiZWenCShiTTCMID: Traditional Chinese Medicine integrative database for herb molecular mechanism analysisNucleic Acids Res201341Database issueD1089D109523203875
  • NémethKPlumbGWBerrinJGDeglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humansEur J Nutr2003421294212594539
  • XuXZhangWHuangCA novel chemometric method for the prediction of human oral bioavailabilityInt J Mol Sci20121366964698222837674
  • LiuHWangJZhouWWangYYangLSystems approaches and polypharmacology for drug discovery from herbal medicines: an example using licoriceJ Ethnopharmacol2013146377379323415946
  • GfellerDGrosdidierAWirthMDainaAMichielinOZoeteVSwissTargetPrediction: a web server for target prediction of bioactive small moleculesNucleic Acids Res201442Web Server issueW32W3824792161
  • SzklarczykDSantosAvon MeringCJensenLJBorkPKuhnMSTITCH 5: augmenting protein-chemical interaction networks with tissue and affinity dataNucleic Acids Res201644D1D380D38426590256
  • ApweilerRBairochAWuCHUniProt: the Universal Protein knowledgebaseNucleic Acids Res200432Database issueD115D11914681372
  • HamoshAScottAFAmbergerJSBocchiniCAMckusickVAOnline Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disordersNucleic Acids Res200433Database issueD514D517
  • RappaportNTwikMPlaschkesIMalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured searchNucleic Acids Res201745D1D877D88727899610
  • AltermannEKlaenhammerTRPathwayVoyager: pathway mapping using the Kyoto Encyclopedia of Genes and Genomes (KEGG) databaseBMC Genomics2005616015869710
  • ShannonPMarkielAOzierOCytoscape: a software environment for integrated models of biomolecular interaction networksGenome Res200313112498250414597658
  • MartinAOchagaviaMERabasaLCMirandaJFernandez-de-CossioJBringasRBisoGenet: a new tool for gene network building, visualization and analysisBMC Bioinformatics20101119120163717
  • ScardoniGPetterliniMLaudannaCAnalyzing biological network parameters with CentiScaPeBioinformatics200925212857285919729372
  • PathanMKeerthikumarSAngCSFunRich: An open access standalone functional enrichment and interaction network analysis toolProteomics201515152597260125921073
  • HarrisMAClarkJIrelandAThe Gene Ontology (GO) database and informatics resourceNucleic Acids Res200432Database issueD258D26114681407
  • TakedaTHosokawaMTakeshitaSA new murine model of accelerated senescenceMech Ageing Dev19811721831947311623
  • YagiHKatohSAkiguchiITakedaTAge-related deterioration of ability of acquisition in memory and learning in senescence accelerated mouse: SAM-P/8 as an animal model of disturbances in recent memoryBrain Res1988474186933214716
  • MiyamotoMCharacteristics of age-related behavioral changes in senescence-accelerated mouse SAMP8 and SAMP10Exp Gerontol1997321–21391489088911
  • TakemuraMNakamuraSAkiguchiIBeta/A4 proteinlike immunoreactive granular structures in the brain of senescence-accelerated mouseAm J Pathol19931426188718978506956
  • CanudasAMGutierrez-CuestaJRodríguezMIHyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM)Mech Ageing Dev2005126121300130416171847
  • ButterfieldDAPoonHFThe senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer’s diseaseExp Gerontol2005401077478316026957
  • FloodJFHarrisFJMorleyJEAge-related changes in hippocampal drug facilitation of memory processing in SAMP8 miceNeurobiol Aging199617115248786798
  • VorheesCVWilliamsMTMorris water maze: procedures for assessing spatial and related forms of learning and memoryNat Protoc20061284885817406317
  • WangTWuZSunLLiWLiuGTangYA Computational Systems Pharmacology Approach to Investigate Molecular Mechanisms of Herbal Formula Tian-Ma-Gou-Teng-Yin for Treatment of Alzheimer’s DiseaseFront Pharmacol2018966829997503
  • SchmidtCWolffMvon AhsenNZerrIAlzheimer’s disease: genetic polymorphisms and rate of declineDement Geriatr Cogn Disord2012332–3848922414550
  • MurrayAPFaraoniMBCastroMJAlzaNPCavallaroVNatural AChE Inhibitors from Plants and their Contribution to Alzheimer’s Disease TherapyCurr Neuropharmacol201311438841324381530
  • SongJHYuJTanLBrain-Derived Neurotrophic Factor in Alzheimer’s Disease: Risk, Mechanisms, and TherapyMol Neurobiol20155231477149325354497
  • D’AmelioMCavallucciVMiddeiSCaspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer’s diseaseNat Neurosci2011141697621151119
  • JiangPLiCXiangZJiaoBTanshinone IIA reduces the risk of Alzheimer’s disease by inhibiting iNOS, MMP2 and NFkappaBp65 transcription and translation in the temporal lobes of rat models of Alzheimer’s diseaseMol Med Rep201410268969424859152
  • GuoLHAlexopoulosPPerneczkyRHeart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer’s diseaseEur Arch Psychiatry Clin Neurosci2013263755356023591828
  • LangeCStorkebaumEde AlmodóvarCRDewerchinMCarmelietPVascular endothelial growth factor: a neurovascular target in neurological diseasesNat Rev Neurol201612843945427364743
  • HanssonOPalmqvistSLjungHCronbergTvan WestenDSmithRCerebral hypoperfusion is not associated with an increase in amyloid β pathology in middle-aged or elderly peopleAlzheimers Dement2018141546128719802
  • WoltersFJZonneveldHIHofmanACerebral Perfusion and the Risk of Dementia: A Population-Based StudyCirculation2017136871972828588075
  • Ha-OhooTTomitaHTakiYThe VEGF gene polymorphism impacts brain volume and arterial blood volumeHum Brain Mapp Epub201741210.1002/hbm.23606
  • LichtTRotheGKreiselTVEGF preconditioning leads to stem cell remodeling and attenuates age-related decay of adult hippocampal neurogenesisProc Natl Acad Sci U S A201611348E7828E783627849577
  • DiQChengZKimWImpaired cross-activation of β3 integrin and VEGFR-2 on endothelial progenitor cells with aging decreases angiogenesis in response to hypoxiaInt J Cardiol201316832167217623452889
  • LähteenvuoJRosenzweigAEffects of aging on angiogenesisCirc Res201211091252126422539758
  • HerranEPerez-GonzalezRIgartuaMPedrazJLCarroEHernandezRMEnhanced Hippocampal Neurogenesis in APP/Ps1 Mouse Model of Alzheimer’s Disease After Implantation of VEGF-loaded PLGA NanospheresCurr Alzheimer Res2015121093294026502822
  • HerránEPérez-GonzálezRIgartuaMPedrazJLCarroEHernándezRMVEGF-releasing biodegradable nanospheres administered by craniotomy: a novel therapeutic approach in the APP/Ps1 mouse model of Alzheimer’s diseaseJ Control Release2013170111111923684689
  • SpuchCAntequeraDPorteroAThe effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer’s diseaseBiomaterials201031215608561820430437
  • Di MarcoLYVenneriAFarkasEEvansPCMarzoAFrangiAFVascular dysfunction in the pathogenesis of Alzheimer’s disease – A review of endothelium-mediated mechanisms and ensuing vicious circlesNeurobiol Dis20158259360626311408
  • KumeKHanyuHSatoTVascular risk factors are associated with faster decline of Alzheimer disease: a longitudinal SPECT studyJ Neurol201125871295130321327852
  • GottesmanRFSchneiderALZhouYAssociation Between Midlife Vascular Risk Factors and Estimated Brain Amyloid DepositionJAMA2017317141443145028399252
  • LiJWangYJZhangMVascular risk factors promote conversion from mild cognitive impairment to Alzheimer diseaseNeurology201176171485149121490316
  • RodrigueKMRieckJRKennedyKMDevousMDDiaz-ArrastiaRParkDCRisk factors for β-amyloid deposition in healthy aging: vascular and genetic effectsJAMA Neurol201370560060623553344
  • Griñán-FerréCCorpasRPuigoriol-IllamolaDPalomera-ÁvalosVSanfeliuCPallàsMUnderstanding Epigenetics in the Neurodegeneration of Alzheimer’s Disease: SAMP8 Mouse ModelJ Alzheimers Dis201862394396329562529
  • KaruppagounderVArumugamSBabuSSThe senescence accelerated mouse prone 8 (SAMP8): A novel murine model for cardiac agingAgeing Res Rev20173529129627825897
  • Agabiti-RoseiCFaveroGde CiuceisCEffect of long-term treatment with melatonin on vascular markers of oxidative stress/inflammation and on the anticontractile activity of perivascular fat in aging miceHypertens Res2017401415027534739
  • Bromley-BritsKDengYSongWMorris water maze test for learning and memory deficits in Alzheimer’s disease model miceJ Vis Exp2011532920
  • SohanakiHBaluchnejadmojaradTNikbakhtFRoghaniMPelargonidin Improves Passive Avoidance Task Performance in a Rat Amyloid Beta25–35 Model of Alzheimer’s Disease Via Estrogen Receptor Independent PathwaysActa Med Iran201654424525027309265
  • RenZZhangRLiYLiYYangZYangHFerulic acid exerts neuroprotective effects against cerebral ischemia/reperfusion-induced injury via antioxidant and anti-apoptotic mechanisms in vitro and in vivoInt J Mol Med20174051444145628901374
  • AsanoTMatsuzakiHIwataNProtective Effects of Ferulic Acid against Chronic Cerebral Hypoperfusion-Induced Swallowing Dysfunction in RatsInt J Mol Sci2017183550
  • KohPOFerulic acid attenuates the down-regulation of MEK/ERK/p90RSK signaling pathway in focal cerebral ischemic injuryNeurosci Lett2015588182325543028
  • LiJZengBHuXProtective Effects of Ginsenoside Rb1 against Blood-Brain Barrier Damage Induced by Human Immunodeficiency Virus-1 Tat Protein and Methamphetamine in Sprague-Dawley RatsAm J Chin Med201846355156629690789
  • WangYLiYYangWGinsenoside Rb1 inhibit apoptosis in rat model of Alzheimer’s disease induced by Aβ1–40Am J Transl Res201810379680529636869
  • MiaoHHZhangYDingGNHongFXDongPTianMGinsenoside Rb1 attenuates isoflurane/surgery-induced cognitive dysfunction via inhibiting neuroinflammation and oxidative stressBiomed Environ Sci201730536337228549492
  • AhmedTRazaSHMaryamAGinsenoside Rb1 as a neuroprotective agent: A reviewBrain Res Bull2016125304327060612
  • JiangZWangYZhangXPreventive and therapeutic effects of ginsenoside Rb1 for neural injury during cerebral infarction in ratsAm J Chin Med201341234135223548124
  • TranTVShinEJDangDKGinsenoside Re protects against phencyclidine-induced behavioral changes and mitochondrial dysfunction via interactive modulation of glutathione peroxidase-1 and NADPH oxidase in the dorsolateral cortex of miceFood Chem Toxicol201711030031529037473
  • TuTTSharmaNShinEJGinsenoside Re Protects Trim-ethyltin-Induced Neurotoxicity via Activation of IL-6-Mediated Phosphoinositol 3-Kinase/Akt Signaling in MiceNeurochem Res201742113125313928884396
  • NamYWieMBShinEJGinsenoside Re protects methamphetamine-induced mitochondrial burdens and proapoptosis via genetic inhibition of protein kinase C δ in human neuroblastoma dopaminergic SH-SY5Y cell linesJ Appl Toxicol201535892794425523949
  • ShenJZhaoZShangWGinsenoside Rg1 nanoparticle penetrating the blood-brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarctionInt J Nanomedicine2017126477648628919749
  • WangYLiuQXuYGinsenoside Rg1 Protects against Oxidative Stress-induced Neuronal Apoptosis through Myosin IIA-actin Related Cytoskeletal ReorganizationInt J Biol Sci201612111341135627877086
  • XieCLWangWWXueXDZhangSFGanJLiuZGA systematic review and meta-analysis of Ginsenoside-Rg1 (G-Rg1) in experimental ischemic strokeSci Rep201551779025600516
  • KuangXZhouHJThorneAHChenXNLiLJDuJRNeuroprotective Effect of Ligustilide through Induction of α-Secretase Processing of Both APP and Klotho in a Mouse Model of Alzheimer’s DiseaseFront Aging Neurosci2017935329163135
  • KuangXChenYSWangLFKlotho upregulation contributes to the neuroprotection of ligustilide in an Alzheimer’s disease mouse modelNeurobiol Aging201435116917823973442
  • WuXMQianZMZhuLNeuroprotective effect of ligustilide against ischaemia-reperfusion injury via up-regulation of erythropoietin and down-regulation of RTP801Br J Pharmacol2011164233234321410687
  • ZhaoTFuYSunHLiuXLigustrazine suppresses neuron apoptosis via the Bax/Bcl-2 and caspase-3 pathway in PC12 cells and in rats with vascular dementiaIUBMB Life2018701607029247598
  • ZhangTGuJWuLNeuroprotective and axonal outgrowth-promoting effects of tetramethylpyrazine nitrone in chronic cerebral hypoperfusion rats and primary hippocampal neurons exposed to hypoxiaNeuropharmacology201711813714728342896
  • LiGTianYZhangYA Novel Ligustrazine Derivative T-VA Prevents Neurotoxicity in Differentiated PC12 Cells and Protects the Brain against Ischemia Injury in MCAO RatsInt J Mol Sci2015169217592177426370988